• LAST PRICE
    3.4000
  • TODAY'S CHANGE (%)
    Trending Up0.0900 (2.7190%)
  • Bid / Lots
    3.3300/ 1
  • Ask / Lots
    3.4500/ 1
  • Open / Previous Close
    3.3400 / 3.3100
  • Day Range
    Low 3.2500
    High 3.4000
  • 52 Week Range
    Low 1.6300
    High 24.7100
  • Volume
    82,540
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 3.31
TimeVolumeVTGN
09:32 ET28113.34
09:36 ET3003.34
09:38 ET19363.3
10:01 ET2003.329
10:06 ET15623.2959
10:08 ET6003.25
10:14 ET2003.28
10:17 ET8883.28
10:21 ET1003.28
10:24 ET1003.27
10:26 ET2073.27
10:28 ET1003.28
10:30 ET5033.29
10:33 ET1003.3
10:39 ET2003.29
10:48 ET12203.29
11:00 ET2503.2912
11:02 ET2003.31
11:04 ET2143.3
11:11 ET1003.3
11:13 ET2833.3
11:18 ET1003.3
11:29 ET4003.305
11:31 ET53183.335
11:36 ET37193.31
11:38 ET1003.325
11:49 ET1003.31
11:58 ET1003.325
12:00 ET1193.325
12:05 ET2703.33
12:12 ET1003.31
12:18 ET5503.325
12:25 ET1003.31
12:32 ET2003.325
12:38 ET6003.325
12:43 ET4003.31
12:48 ET2003.315
12:57 ET1003.315
01:03 ET2003.315
01:08 ET1003.33
01:10 ET5103.3299
01:12 ET1253.32
01:14 ET2003.32
01:15 ET21143.295
01:17 ET3003.28
01:19 ET9503.28
01:21 ET2003.29
01:24 ET1003.27
01:30 ET12003.27
01:33 ET3593.28
01:39 ET4003.29
01:42 ET2003.33
01:48 ET2063.34
01:53 ET1003.345
01:55 ET33123.3516
02:00 ET39083.36
02:04 ET1003.365
02:06 ET2973.36
02:13 ET5333.35
02:18 ET4003.355
02:20 ET1003.35
02:24 ET1003.35
02:33 ET1003.35
02:40 ET4003.36
02:44 ET1003.34
02:45 ET1003.35
02:49 ET2243.3459
02:56 ET2003.35
03:02 ET2003.35
03:05 ET1003.34
03:09 ET14533.39
03:16 ET1003.39
03:25 ET1003.37
03:27 ET1003.37
03:30 ET1003.37
03:38 ET2003.37
03:41 ET1003.36
03:43 ET10003.366
03:45 ET6003.38
03:48 ET34163.35
03:56 ET7703.36
03:57 ET5003.37
03:59 ET150073.4
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVTGN
Vistagen Therapeutics Inc
91.9M
-1.6x
---
United StatesACET
Adicet Bio Inc
87.9M
-0.4x
---
United StatesSGMT
Sagimet Biosciences Inc
94.5M
-2.4x
---
United StatesANVS
Annovis Bio Inc
124.0M
-2.2x
---
United StatesRLMD
Relmada Therapeutics Inc
91.1M
-1.0x
---
United StatesCTXR
Citius Pharmaceuticals Inc
95.6M
-2.2x
---
As of 2024-07-06

Company Information

Vistagen Therapeutics, Inc. is a neuroscience-focused biopharmaceutical company. The Company is engaged in the development and commercialization of therapies for psychiatric and neurological disorders based on its understanding of nose-to-brain neurocircuitry. Its clinical-stage pipeline consists of intranasal product candidates from a new class of potential neuroscience therapies called pherines. Its diversified pipeline of pherine product candidates rapidly activate chemosensory neurons in the nasal cavity to impact fundamental neurocircuitry in the olfactory system and the brain. Its pipeline also includes an oral prodrug with potential to modulate N-methyl-D-aspartate receptor (NMDA) receptor activity. Its neuroscience pipeline includes five clinical-stage investigational agent, namely Fasedienol (PH94B), Itruvone (PH10), AV-101, PH15, PH80, and PH284.

Contact Information

Headquarters
343 ALLERTON AVENUESOUTH SAN FRANCISCO, CA, United States 94080
Phone
650-577-3600
Fax
---

Executives

Independent Chairman of the Board
Margaret Fitzpatrick
Chief Executive Officer, Director
Shawn Singh
Chief Financial Officer
Cynthia Anderson
Chief Operating Officer
Joshua Prince
Senior Vice President - Investor Relations
Mark Mcpartland

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$91.9M
Revenue (TTM)
$1.1M
Shares Outstanding
27.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.75
EPS
$-2.12
Book Value
$4.23
P/E Ratio
-1.6x
Price/Sales (TTM)
86.4
Price/Cash Flow (TTM)
---
Operating Margin
-3,103.48%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.